The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
The role of protein glycosylation in Alzheimer disease
Abstract
Glycosylation is one of the most common, and the most complex, forms of post‐translational modification of proteins. This review serves to highlight the role of protein glycosylation in Alzheimer disease (AD), a topic that has not been thoroughly investigated, although glycosylation defects have been observed in AD patients. The major pathological hallmarks in AD are neurofibrillary tangles and amyloid plaques. Neurofibrillary tangles are composed of phosphorylated tau, and the plaques are composed of amyloid β‐peptide (Aβ), which is generated from amyloid precursor protein (APP). Defects in glycosylation of APP, tau and other proteins have been reported in AD. Another interesting observation is that the two proteases required for the generation of amyloid β‐peptide (Aβ), i.e. γ‐secretase and β‐secretase, also have roles in protein glycosylation. For instance, γ‐secretase and β‐secretase affect the extent of complex N‐glycosylation and sialylation of APP, respectively. These processes may be important in AD pathogenesis, as proper intracellular sorting, processing and export of APP are affected by how it is glycosylated. Furthermore, lack of one of the key components of γ‐secretase, presenilin, leads to defective glycosylation of many additional proteins that are related to AD pathogenesis and/or neuronal function, including nicastrin, reelin, butyrylcholinesterase, cholinesterase, neural cell adhesion molecule, v‐ATP ase, and tyrosine‐related kinase B. Improved understanding of the effects of AD on protein glycosylation, and vice versa, may therefore be important for improving the diagnosis and treatment of AD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,083
Varki, A. P., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Etzler, M. E. (1999) · Cited by 2,384
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997
Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901
Lee, J.-H., Yu, W. H., Kumar, A., Lee, S., Mohan, P. S., Peterhoff, C. M., Wolfe, D. M., Martinez-Vicente, M., Massey, A. C., Sovak, G., et al. (2010) · Cell · doi:10.1016/j.cell.2010.05.008 · Cited by 1,212
Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing
Yu, G., Nishimura, M., Arawaka, S., Levitan, D., Zhang, L., Tandon, A., Song, Y.-Q., Rogaeva, E., Chen, F., Kawarai, T., et al. (2000) · Nature · doi:10.1038/35024009 · Cited by 911
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., & Gong, C.-X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400348101 · Cited by 775
Glycans and neural cell interactions
Kleene, R., & Schachner, M. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1349 · Cited by 521
Liu, F., Shi, J., Tanimukai, H., Gu, J., Gu, J., Grundke-Iqbal, I., Iqbal, K., & Gong, C.-X. (2009) · Brain · doi:10.1093/brain/awp099 · Cited by 439
The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine
Arnold, C. S., Johnson, G. W., Cole, R. N., Dong, D. L.-Y., Lee, M., & Hart, G. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28741 · Cited by 361
Wang, J.-Z., Grundke-Iqbal, I., & Iqbal, K. (1996) · Nature Medicine · doi:10.1038/nm0896-871 · Cited by 360
Effects of PS1 Deficiency on Membrane Protein Trafficking in Neurons
Naruse, S., Thinakaran, G., Luo, J.-J., Kusiak, J. W., Tomita, T., Iwatsubo, T., Qian, X., Ginty, D. D., Price, D. L., Borchelt, D. R., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80637-6 · Cited by 355
Enrichment of glycopeptides for glycan structure and attachment site identification
Nilsson, J., Rüetschi, U., Halim, A., Hesse, C., Carlsohn, E., Brinkmalm, G., & Larson, G. (2009) · Nature Methods · doi:10.1038/nmeth.1392 · Cited by 322
García-Ayllón, M.-S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00022 · Cited by 299
Wang, Z., Udeshi, N. D., O'Malley, M., Shabanowitz, J., Hunt, D. F., & Hart, G. W. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900268-mcp200 · Cited by 261
A Comprehensive Genetic Association Study of Alzheimer Disease in African Americans
Logue, M. W. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.646 · Cited by 249
Halim, A., Brinkmalm, G., Rüetschi, U., Westman-Brinkmalm, A., Portelius, E., Zetterberg, H., Blennow, K., Larson, G., & Nilsson, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102664108 · Cited by 246
Kitazume, S., Tachida, Y., Oka, R., Shirotani, K., Saido, T. C., & Hashimoto, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241509198 · Cited by 232
Edbauer, D., Winkler, E., Haass, C., & Steiner, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132277899 · Cited by 225
Reelin expression and glycosylation patterns are altered in Alzheimer’s disease
Botella-López, A., Burgaya, F., Gavín, R., García-Ayllón, M. S., Gómez-Tortosa, E., Peña-Casanova, J., Ureña, J. M., Del Río, J. A., Blesa, R., Soriano, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601279103 · Cited by 221
Oligosaccharyltransferase: the central enzyme of N‐linked protein glycosylation
Mohorko, E., Glockshuber, R., & Aebi, M. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9337-1 · Cited by 214
Herreman, A., Van Gassen, G., Bentahir, M., Nyabi, O., Craessaerts, K., Mueller, U., Annaert, W., & De Strooper, B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00292 · Cited by 195
Tomita, S., Kirino, Y., & Suzuki, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6277 · Cited by 189
Annaert, W. G., Esselens, C., Baert, V., Boeve, C., Snellings, G., Cupers, P., Craessaerts, K., & De Strooper, B. (2001) · Neuron · doi:10.1016/s0896-6273(01)00512-8 · Cited by 184
Presenilin 1 Is Required for Maturation and Cell Surface Accumulation of Nicastrin
Leem, J. Y., Vijayan, S., Han, P., Cai, D., Machura, M., Lopes, K. O., Veselits, M. L., Xu, H., & Thinakaran, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200148200 · Cited by 181
Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease
Liu, F., Zaidi, T., Iqbal, K., Grundke-Iqbal, I., Merkle, R. K., & Gong, C.-X. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02228-7 · Cited by 167
Mature Glycosylation and Trafficking of Nicastrin Modulate Its Binding to Presenilins
Yang, D.-S., Tandon, A., Chen, F., Yu, G., Yu, W. H., Arawaka, S., Hasegawa, H. H., Duthie, M., Schmidt, S. D., Ramabhadran, T. V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110871200 · Cited by 158
β‐Amyloid precursor protein is modified with O‐linked N‐acetylglucosamine
Griffith, L. S., Mathes, M., & Schmitz, B. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410214 · Cited by 154
Aβ43 is more frequent than Aβ40 in amyloid plaque cores from Alzheimer disease brains
Welander, H., Frånberg, J., Graff, C., Sundström, E., Winblad, B. G., & Tjernberg, L. O. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06170.x · Cited by 152
Self-citationSmet‐Nocca, C., Broncel, M., Wieruszeski, J., Tokarski, C., Hanoulle, X., Leroy, A., Landrieu, I., Rolando, C. H., Lippens, G. M., & Hackenberger, C. P. R. (2011) · Molecular BioSystems · doi:10.1039/c0mb00337a · Cited by 141
Perdivara, I., Petrovich, R. M., Allinquant, B., Deterding, L. J., Tomer, K. B., & Przybylski, M. (2008) · Journal of Proteome Research · doi:10.1021/pr800758g · Cited by 133
Autophagy deregulation in neurodegenerative diseases – recent advances and future perspectives
Cheung, Z. H., & Ip, N. Y. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07314.x · Cited by 132
The beta‐amyloid domain is essential for axonal sorting of amyloid precursor protein.
Tienari, P. J., Strooper, B. D., Ikonen, E., Simons, M., Weidemann, A., Czech, C., Hartmann, T., Ida, N., Multhaup, G., Masters, C. L., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00907.x · Cited by 131
Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody
Yuzwa, S. A., Yadav, A. K., Skorobogatko, Y., Clark, T., Vosseller, K., & Vocadlo, D. J. (2011) · Amino Acids · doi:10.1007/s00726-010-0705-1 · Cited by 130
Gong, C., Liu, F., Grundke-Iqbal, I., & Iqbal, K. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9101 · Cited by 128
Concurrent alterations of O‐GlcNAcylation and phosphorylation of tau in mouse brains during fasting
Li, X., Fen, L., Wang, J., & Gong, C. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04735.x · Cited by 122
Zhang, X., Garbett, K., Veeraraghavalu, K., Wilburn, B., Gilmore, R., Mirnics, K., & Sisodia, S. S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0556-12.2012 · Cited by 122
Kim, C., Nam, D. W., Park, S. Y., Song, H., Hong, H. S., Boo, J. H., Jung, E. S., Kim, Y., Baek, J. Y., Kim, K. S., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.001 · Cited by 121
Kitazume, S., Tachida, Y., Kato, M., Yamaguchi, Y., Honda, T., Hashimoto, Y., Wada, Y., Saito, T., Iwata, N., Saido, T. C., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.144626 · Cited by 120
Tayeb, H. O., Murray, E. D., Price, B. H., & Tarazi, F. I. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.789856 · Cited by 119
Halim, A., Rüetschi, U., Larson, G., & Nilsson, J. (2012) · Journal of Proteome Research · doi:10.1021/pr300963h · Cited by 118
Liu, F., Zaidi, T., Iqbal, K., Grundke, I., & Gong, C. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00510-9 · Cited by 113
O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP)
Jacobsen, K. T., & Iverfeldt, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.080 · Cited by 113
Characterization of α2,6-Sialyltransferase Cleavage by Alzheimer's β-Secretase (BACE1)
Kitazume, S., Tachida, Y., Oka, R., Kotani, N., Ogawa, K., Suzuki, M., Dohmae, N., Takio, K., Saido, T. C., & Hashimoto, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206262200 · Cited by 111
Nyabi, O., Bentahir, M., Horré, K., Herreman, A., Gottardi-Littell, N. R., Broeckhoven, C. V., Merchiers, P., Spittaels, K., Annaert, W. G., & Strooper, B. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306957200 · Cited by 111
Sáez‐Valero, J., Sberna, G., McLean, C., & Small, D. H. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721600.x · Cited by 108
Sihlbom, C., Davidsson, P., Sjögren, M. J. C., Wahlund, L., & Nilsson, C. L. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9588-x · Cited by 104
Akasaka‐Manya, K., Manya, H., Sakurai, Y., Wójczyk, B. S., Kozutsumi, Y., Saito, Y., Taniguchi, N., Murayama, S., Spitalnik, S. L., & Endo, T. (2009) · Glycobiology · doi:10.1093/glycob/cwp152 · Cited by 102
Owen, J. B., Domenico, F. D., Rukhsana Sultana, A., Marzia Perluigi, A., Cini, C., Pierce, W. M. J., & Butterfield, D. A. (2008) · Journal of Proteome Research · doi:10.1021/pr800667a · Cited by 102
Active γ‐secretase is localized to detergent‐resistant membranes in human brain
Hur, J., Welander, H., Behbahani, H., Aoki, M., Frånberg, J., Winblad, B. G., Frykman, S., & Tjernberg, L. O. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06278.x · Cited by 101
Self-citationGlycosylation changes in Alzheimer’s disease as revealed by a proteomic approach
Kanninen, K. M., Goldsteins, G., Auriola, S. O. K., Alafuzoff, I. I., & Koıstınaho, J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.013 · Cited by 97
γ-Secretase Activity Is Associated with a Conformational Change of Nicastrin
Shirotani, K., Edbauer, D., Capell, A., Schmitz, J., Steiner, H., & Haass, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300095200 · Cited by 96
Brinkmalm, G., Portelius, E., Öhrfelt, A., Mattsson, N., Persson, R., Gustavsson, M. K., Vite, C. H., Gobom, J., Månsson, J., Nilsson, J., et al. (2012) · Journal of Mass Spectrometry · doi:10.1002/jms.2987 · Cited by 92
Deng, Y., Li, B., Liu, F., Iqbal, K., Grundke, I., Brandt, R., & Gong, C. (2007) · The FASEB Journal · doi:10.1096/fj.07-8309com · Cited by 88
Sato, Y., Naito, Y., Grundke, I., Iqbal, K., & Endo, T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02421-8 · Cited by 85
Sialylation enhances the secretion of neurotoxic amyloid‐β peptides
Nakagawa, K., Kitazume, S., Oka, R., Maruyama, K., Saido, T. C., Sato, Y., Endo, T., & Hashimoto, Y. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03595.x · Cited by 83
In Vivo Cleavage of α2,6-Sialyltransferase by Alzheimer β-Secretase
Kitazume, S., Nakagawa, K., Oka, R., Tachida, Y., Ogawa, K., Luo, Y., Citron, M., Shitara, H., Taya, C., Yonekawa, H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409417200 · Cited by 79
N-linked glycosylation of β-amyloid precursor protein
Påhlsson, P., Shakin-Eshleman, S. H., & Spitalnik, S. L. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90269-q · Cited by 78
A unique N-glycan on human transferrin in CSF: a possible biomarker for iNPH
Futakawa, S., Nara, K., Miyajima, M., Kuno, A., Ito, H., Kaji, H., Shirotani, K., Honda, T., Tohyama, Y., Hoshi, K., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.023 · Cited by 75
Shirotani, K., Edbauer, D., Kostka, M., Steiner, H., & Haass, C. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02447.x · Cited by 73
Increased frequency of the transferrin C2 subtype in Alzheimerʼs disease
van Rensburg, S. J., Carstens, M. E., Potocnik, F. C. V., Aucamp, A. K., & Taljaard, J. J. F. (1993) · Neuroreport · doi:10.1097/00001756-199309000-00015 · Cited by 68
β-amyloid controls altered Reelin expression and processing in Alzheimer's disease
Botella-López, A., Cuchillo‐Ibáñez, I., Cotrufo, T., Mok, S. S., Li, Q., Jiménez, M. S. B., Dierssen, M., Soriano, E., & Sáez‐Valero, J. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.006 · Cited by 65
Complex N‐glycosylated form of nicastrin is stabilized and selectively bound to presenilin fragments
Tomita, T., Katayama, R., Takikawa, R., & Iwatsubo, T. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02802-8 · Cited by 65
Sugimoto, I., Futakawa, S., Oka, R., Ogawa, K., Marth, J. D., Miyoshi, E., Taniguchi, N., Hashimoto, Y., & Kitazume, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704766200 · Cited by 60
Sáez‐Valero, J., Fodero, L. R., Sjögren, M. J. C., Andreasen, N. C., Amici, S., Gallai, V., Vanderstichele, H., Vanmechelen, E., Parnetti, L., Blennow, K., et al. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10599 · Cited by 60
The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer’s disease
Deng, Y., Liu, L., Wang, Y., Tang, H., Ren, R., Xu, W. L., Ma, J., Wang, L., Zhuang, J.-P., Wang, G., et al. (2012) · Human Genetics · doi:10.1007/s00439-012-1154-6 · Cited by 54
Transferrin C2, metal binding and Alzheimerʼs disease
van Landeghem, G. F., Sikström, C., Beckman, L. E., Adolfsson, R., & Beckman, L. E. (1998) · Neuroreport · doi:10.1097/00001756-199801260-00001 · Cited by 53
McFarlane, I., Georgopoulou, N., Coughlan, C. M., Gillian, A. M., & Breen, K. C. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00361-3 · Cited by 53
A decrease in serum sialyltransferase levels in Alzheimer's disease
Maguire, T. M., Gillian, A. M., O’Mahony, D., Coughlan, C. M., & Breen, K. C. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90149-x · Cited by 51
A Decrease in Neural Sialyltransferase Activity in Alzheimer’s Disease
Maguire, T. M., & Breen, K. C. (1995) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106944 · Cited by 50
Wheat germ agglutinin‐binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid
Fodero, L. R., Sáez‐Valero, J., Jiménez, M. S. B., Marcos, A., McLean, C., & Small, D. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00640.x · Cited by 49
Sugar Chains of Cerebrospinal Fluid Transferrin as a New Biological Marker of Alzheimer’s Disease
Taniguchi, M., Okayama, Y., Hashimoto, Y., 北浦美貴, Jimbo, D., Wakutani, Y., Wada‐Isoe, K., Nakashima, K., Akatsu, H., Furukawa, K., et al. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000147479 · Cited by 45
Increased bisecting and core-fucosylated N-glycans on mutant human amyloid precursor proteins
Akasaka‐Manya, K., Manya, H., Sakurai, Y., Wójczyk, B. S., Spitalnik, S. L., & Endo, T. (2008) · Glycoconjugate Journal · doi:10.1007/s10719-008-9140-x · Cited by 45
Yazaki, M., Tagawa, K., Maruyama, K., Sorimachi, H., Tsuchiya, T., Ishiura, S., & Suzuki, K. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13285-7 · Cited by 43
Sáez‐Valero, J. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.5.664 · Cited by 42
Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease
Sáez‐Valero, J., Sberna, G., McLean, C., Masters, C. L., & Small, D. H. (1997) · The Lancet · doi:10.1016/s0140-6736(97)24039-0 · Cited by 41
Domenico, F. D., Owen, J. B., Rukhsana Sultana, A., Robinson, R. A. S., Marzia Perluigi, A., Cini, C., Cai, J., Pierce, W. M. J., & Butterfield, D. A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22528 · Cited by 40
Nilsson, J., Halim, A., Grahn, A., & Larson, G. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9438-6 · Cited by 40
Hashimoto, M., Bogdanović, N., Nakagawa, H., Volkmann, I., Aoki, M., Winblad, B. G., Sakai, J., & Tjernberg, L. O. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01441.x · Cited by 38
Self-citationButterfield, D. A., & Owen, J. B. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000070 · Cited by 38
5- and 6-Glycosylation of Transferrin in Patients with Alzheimer's Disease
van Rensburg, S. J., Berman, P., Potocnik, F. C. V., Macgregor, P. M., Hon, D., & de Villiers, N. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000027420.50736.62 · Cited by 36
Inhibition of N-glycan processing alters axonal transport of synaptic glycoproteins in vivo
McFarlane, I., Breen, K. C., Giamberardino, L. D., & Moya, K. L. (2000) · Neuroreport · doi:10.1097/00001756-200005150-00036 · Cited by 34
Mass spectrometry for comparative proteomics of degenerative and regenerative processes in the brain
Sihlbom, C. (2006) · Gothenburg University Publications Electronic Archive (Gothenburg University) · doi:10.1016/j.ijms.2004.02.016 · Cited by 32
Presenilin 1 Interacts with Acetylcholinesterase and Alters Its Enzymatic Activity and Glycosylation
Silveyra, M. X., Evin, G. M., Montenegro, M. F., Vidal, C. J., Martı́nez, S., Culvenor, J. G., & Sáez‐Valero, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02065-07 · Cited by 32
Inhibition of N-glycan processing alters axonal transport of synaptic glycoproteins in vivo.
McFarlane, I., Breen, K. C., Giamberardino, L. D., & Moya, K. L. (2000) · PubMed · Cited by 27
Sato, Y., Liu, C., Wójczyk, B. S., Kobata, A., Spitalnik, S. L., & Endo, T. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00140-3 · Cited by 26
Mannose-Binding Lectin Binds to Amyloid Protein and Modulates Inflammation
Larvie, M., Shoup, T. M., Chang, W., Chigweshe, L., Hartshorn, K. L., White, M. R., Stahl, G. L., Elmaleh, D. R., & Takahashi, K. (2012) · BioMed Research International · doi:10.1155/2012/929803 · Cited by 26
van Rensburg, S. J., Potocnik, F. C. V., de Villiers, J. N. P., Kotze, M. J., & Taljaard, J. J. F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06369.x · Cited by 26
An unusually glycosylated form of acetylcholinesterase is a CSF biomarker for Alzheimer's disease
Sáez‐Valero, J., Ss, S. S. S., & Small, D. H. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00307.x · Cited by 22
Screening a series of sialyltransferases for possible BACE1 substrates
Kitazume, S., Tachida, Y., Oka, R., Nakagawa, K., Takashima, S., Lee, Y., & Hashimoto, Y. (2006) · Glycoconjugate Journal · doi:10.1007/s10719-006-6671-x · Cited by 18
Sihlbom, C., Davidsson, P., & Nilsson, C. L. (2005) · Journal of Proteome Research · doi:10.1021/pr050210g · Cited by 18
Saito, F., Yanagisawa, K., & Miyatake, T. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90164-k · Cited by 18
Farquhar, M. J., Gray, C. W., & Breen, K. C. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00544-5 · Cited by 16
Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in alzheimer’s disease
Sáez‐Valero, J., & Small, D. H. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03144-9 · Cited by 16
Alzheimer's β-secretase cleaves a glycosyltransferase as a physiological substrate
Kitazume, S., Saido, T. C., & Hashimoto, Y. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000016743.25495.45 · Cited by 16
Kitazume, S., Suzuki, M., Saido, T. C., & Hashimoto, Y. (2004) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000043743.21735.ff · Cited by 16
Uchihara, T., Sanjo, N., Nakamura, A., Han, K., Song, S., George‐Hyslop, P. S., & Fraser, P. E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.12.011 · Cited by 15
Cellular distribution of γ-secretase subunit nicastrin in the developing and adult rat brains
Kodam, A., Vetrivel, K. S., Thinakaran, G., & Kar, S. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.005 · Cited by 14
Genetic aspects of amyloid beta-protein fibrillogenesis in Alzheimer's disease.
Kowalska, A. (2004) · PubMed · Cited by 13
Microheterogeneity of some serum glycoproteins in neurodegenerative diseases
Marklová, E., Albahri, Z., & Vališ, M. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.11.006 · Cited by 9
Cited by
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
Self-citationAn atomic structure of human γ-secretase
Bai, X.-C., Yan, C., Yang, G., Lu, P., Ma, D., Sun, L., Zhou, R., Scheres, S. H. W., & Shi, Y. (2015) · Nature · doi:10.1038/nature14892 · Cited by 498
2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy
Zhang, D., Li, J., Wang, F., Hu, J., Wang, S., & Sun, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.003 · Cited by 462
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics
Thomas, D., Rathinavel, A. K., & Radhakrishnan, P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188464 · Cited by 372
Alquezar, C., Arya, S., & Kao, A. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.595532 · Cited by 367
Metadata
- Authors
- Schedin‐Weiss, S., Winblad, B., & Tjernberg, L. O.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2013-11-26
- Volume
- 281
- Issue
- 1
- Pages
- 46-62
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2071292969
- Cited by
- 317
- References
- 100
- FWCI
- 14.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.